Studies on actively allergised cells. 3. Suppression of the allergic response with specific antibody and the effect of this treatment on plaque and rosette-forming cells.
D000485:Allergens; D000818:Animals; D000888:Antibodies, Anti-Idiotypic; D000917:Antibody Formation / Q000187:drug effects*; D000918:Antibody Specificity; D000921:Antibody-Producing Cells; D000937:Antigen-Antibody Reactions; D003298:Coombs Test; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D006462:Hemolytic Plaque Technique; D006967:Hypersensitivity / Q000276:immunology*; D007106:Immune Sera / Q000008:administration & dosage; D007111:Immunity, Cellular; D007112:Immunity, Maternally-Acquired; D007120:Immunochemistry; D007074:Immunoglobulin G / Q000494:pharmacology; D007136:Immunoglobulins / Q000032:analysis; D008198:Lymph Nodes / Q000276:immunology*; D008297:Male; D008623:Mercaptoethanol / Q000494:pharmacology; D051379:Mice; D009363:Neoplasm Proteins; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental; D010434:Pepsin A / Q000494:pharmacology; D010954:Plasmacytoma / Q000276:immunology; D011817:Rabbits; D012756:Sheep
D000485:Allergens; D000888:Antibodies, Anti-Idiotypic; D007106:Immune Sera; D007074:Immunoglobulin G; D007136:Immunoglobulins; D009363:Neoplasm Proteins; D008623:Mercaptoethanol; D010434:Pepsin A